ArticleInsights into imaging2025
Annotation-efficient, patch-based, explainable deep learning using curriculum method for breast cancer detection in screening mammography.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- PatchChestCT: A patch-level spatial annotation dataset for nine abnormalities in chest CT.Scientific data · 2026Article
- Explainable Artificial Intelligence in Mammography: A Systematic Review of Methods, Evaluation Practices, and Clinical Readiness.Diagnostics (Basel, Switzerland) · 2026Review
- Improving Normal/Abnormal and Benign/Malignant Classifications in Mammography with ROI-Stratified Deep Learning.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo develop an efficient deep learning (DL) model for breast cancer detection in mammograms, utilizing both weak (image-level) and strong (bounding boxes) annotations and providing explainable artificial intelligence (XAI) with gradient-weighted class activation mapping (Grad-CAM), assessed by the ground truth overlap ratio.
methodsThree radiologists annotated a balanced dataset of 1976 mammograms (cancer-positive and -negative) from three centers. We developed a patch-based DL model using curriculum learning, progressively increasing patch sizes during training. The model was trained under varying levels of strong supervision (0%, 20%, 40%, and 100% of the dataset), resulting in baseline, curriculum 20, curriculum 40, and curriculum 100 models. Training for each model was repeated ten times, with results presented as mean ± standard deviation. Model performance was also tested on an external dataset of 4276 mammograms to assess generalizability.
resultsF1 scores for the baseline, curriculum 20, curriculum 40, and curriculum 100 models were 80.55 ± 0.88, 82.41 ± 0.47, 83.03 ± 0.31, and 83.95 ± 0.55, respectively, with ground truth overlap ratios of 60.26 ± 1.91, 62.13 ± 1.2, 62.26 ± 1.52, and 64.18 ± 1.37. In the external dataset, F1 scores were 74.65 ± 1.35, 77.77 ± 0.73, 78.23 ± 1.78, and 78.73 ± 1.25, respectively, maintaining a similar performance trend.
conclusionTraining DL models with a curriculum method and a patch-based approach yields satisfactory performance and XAI, even with a limited set of densely annotated data, offering a promising avenue for deploying DL in large-scale mammography datasets. CRITICAL RELEVANCE: This study introduces a DL model for mammography-based breast cancer detection, utilizing curriculum learning with limited, strongly labeled data. It showcases performance gains and better explainability, addressing challenges of extensive dataset needs and DL's "black-box" nature. KEY POINTS: Increasing numbers of mammograms for radiologists to interpret pose a logistical challenge. We trained a DL model leveraging curriculum learning with mixed annotations for mammography. The DL model outperformed the baseline model with image-level annotations using only 20% of the strong labels. The study addresses the challenge of requiring extensive datasets and strong supervision for DL efficacy. The model demonstrated improved explainability through Grad-CAM, verified by a higher ground truth overlap ratio. He proposed approach also yielded robust performance on external testing data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.